Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
STAND
1 other identifier
observational
30
1 country
1
Brief Summary
The objectives of this study are:
- To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND)
- To assess common constructs and correlation between STAND subscale items.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 27, 2014
CompletedFirst Posted
Study publicly available on registry
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedNovember 16, 2021
November 1, 2021
3.7 years
June 27, 2014
November 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Inter- and intra-rater agreement
Assess agreement between raters (inter-rater agreement) and within raters (intra-rater agreement) through the evaluation of STAND total score, subtotals and individual variables using intraclass correlation coefficients (ICCs).
4 to 6 weeks
Study Arms (1)
Subjects with Ataxia
Patients with a diagnosis of ataxia (Friedreich's ataxia or Spinocerebellar ataxia type 1-30) aged 18-80 years old will be recruited for the study.
Interventions
Administer new rating scale for ataxia. This will be administered by two different raters on two separate occassions, 4 to 6 weeks apart.
Eligibility Criteria
Community members, support group members or clinic patients with ataxia.
You may qualify if:
- Diagnosis of ataxia.
- Male or female between 18 and 80 years of age.
- Subject has voluntarily signed an IRB approved informed consent form to participate in the study after all relevant aspects of the study have been explained and discussed with the subject.
You may not qualify if:
- Any illness that in the investigator's opinion preclude participation in this study.
- Subjects with a cardiac pacemaker
- Legal incapacity or limited legal capacity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of South Florida
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurology
Study Record Dates
First Submitted
June 27, 2014
First Posted
July 1, 2014
Study Start
October 1, 2012
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
November 16, 2021
Record last verified: 2021-11